Erratum to ※DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil§

作者：Annelise Pezzi; Lauro Moraes; Vanessa Valim; Bruna Amorin; Gabriela Melchiades; Fernanda Oliveira; Maria Aparecida da Silva; Ursula Matte; Maria S Pombo de Oliveira; Rosane Bittencourt; Liane Daudt; Lucia Silla

来源：Advances in Hematology, 2014, 2014: 1-2.

DOI：10.1155/2014/148472

The purpose of this note is to correct both the analysis and typographical errors.The typos are as follows. ˋThe abstract, line 6: In ※in 6 patients (8%)§ should read ※in 5 patients (6%)§.ˋPage 4, line 12: In ※8% (6) of the samples, being 5 missens§ should read ※6% (5) of the samples, being 4 missense§.ˋPage 4, line 19: In ※Of the 6 cases§ should read ※Of the 5 cases§.ˋPage 4, line 20: In ※(5, or 83.3%)§ should read ※(4, or 80%)§.ˋPage 4, second column, line 8: In ※OS for patients with wild DNMT3A gene was 41.4% and for patients with mutated DNMT3A was 44.4% ( )§ should read ※OS for patients with wild DNMT3A gene was 45.7% and for patients with mutated DNMT3A was 60.0% ( )§.ˋPage 6, line 4: In ※found in 8%§ should read ※found in 6%§.ˋPage 6, second column, line 13: In ※3 of 6 mutations§ should read ※3 of 5 mutations§.ˋPage 6, second column, line 16: In ※Five, or 80%,§ should read ※Four, or 80%,§.ˋPage 6, second column, line 18: In ※( )§ should read ※( )§.ˋPage 6, second column, line 20: In ※(20.7 ℅ 109/L)§ should read ※(15.6 ℅ 109/L)§.ˋTable 4, column 2, line 6: In ※H896*§ should read ※P896*§.ˋTable 4: Entire line 7 was excluded.ˋTable 5, line 2: In ※40.2, 44.8 and 0.56§ should read ※47.4, 40.4 and 0.42§.ˋTable 5, line 4: In ※50% (3), 59.3% (45) and 0.68§ should read ※60% (3), 57.9% (44) and 0.92§.ˋTable 5, line 5: In ※50% (3), 40.7% (31)§ should read ※40% (2), 42.1% (32)§.ˋTable 5, line 19: In ※50% (3), 51.4% (37) and 1.000§ should read ※40% (2), 52.7% (39) and 0.66§.ˋTable 5, line 20: In ※50% (2), 30.9% (17) and 0.58§ should read ※40% (2), 29.2% (21) and 0.63§.ˋWe changed Figure 3 as shown above. Table 4: Description of somatic mutations found in gene DNMT3A. Table 5: Clinical characteristics of patients with Acute Myeloid Leukemia with or without DNMT3A mutations. Figure 3